Clinical Trials on Adolescents Obesity in Japan
Total 53 results
-
Chiba UniversityCompletedAdolescent | DepressionJapan
-
Hiroshima UniversityBiostir, Inc.; MIONA Co., Ltd.Completed
-
Novo Nordisk A/SCompleted
-
Hiroshima UniversityUnitika Ltd.Completed
-
SanofiTerminated
-
Novo Nordisk A/SNot yet recruiting
-
Eli Lilly and CompanyRecruitingAdolescent | Neoplasms | ChildUnited States, Spain, United Kingdom, Australia, Italy, Japan, Belgium, France, Germany
-
Eli Lilly and CompanyRecruiting
-
Kagoshima UniversityUnknown
-
Janssen Pharmaceutical K.K.CompletedAutistic Disorder in Children and AdolescentsJapan
-
SanofiTerminatedObesity | Diabetes Mellitus Type 2Japan
-
SanofiTerminatedObesity | Diabetes Mellitus Type 2Japan
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Wafaa Mahmoud AminCairo UniversityCompletedOverweight and Obesity | Balance; DistortedSaudi Arabia
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
University of JazanCompletedCoronary Artery Disease | ObesitySaudi Arabia
-
Wafaa Mahmoud AminCairo UniversityCompletedOverweight and Obesity | Motor Activity | Hand InjuriesSaudi Arabia
-
Eli Lilly and CompanyActive, not recruiting
-
Rhythm Pharmaceuticals, Inc.Enrolling by invitationHypothalamic ObesityUnited States, Canada, Japan, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyCompleted
-
University of JazanRecruitingObesity | Body Weight | Smartphone Addiction | Cervical Myofascial Pain SyndromeSaudi Arabia
-
Eisai LimitedCompleted
-
PfizerCompletedPrader-Willi SyndromeJapan
-
Bispebjerg HospitalWorld Health Organization; International Network of Health Promoting Hospitals... and other collaboratorsCompletedSmoking | Obesity | Malnutrition | Excessive Drinking | Lack of Physical ActivityCanada, Croatia, Czechia, Denmark, Estonia, Indonesia, Japan, Malaysia, Slovenia, Taiwan, Thailand
-
Boehringer IngelheimActive, not recruiting
-
Novo Nordisk A/SCompletedObesity | OverweightJapan, Korea, Republic of
-
Novartis PharmaceuticalsCompleted
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Overweight or ObesityUnited States, China, India, Taiwan, Japan, Brazil, Puerto Rico, Spain, Korea, Republic of, Slovakia
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
PfizerCompletedObesityUnited States, Taiwan, Canada, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
-
Novo Nordisk A/SRecruitingObesityUnited States, Australia, Japan
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Boehringer IngelheimActive, not recruitingObesityUnited States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Canada, Netherlands, New Zealand, Sweden, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Japan, Mexico, Brazil, Puerto Rico, Argentina, Russian Federation
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Korea, Republic of, Belgium, Spain, China, Australia, Hungary, Canada, Czechia, Poland, New Zealand, Denmark, Finland, Germany, Greece, Netherlands, Sweden, Japan, United Kingdom